Why Affordable Care Act Health Insurance Is More Expensive Than Ever

Health insurance premiums on the Affordable Care Act (ACA) marketplaces have surged to new highs in 2026, leaving millions of Americans grappling with sharply rising costs for essential coverage. While the exact drivers of this trend have not yet been quantified in peer-reviewed research, industry analysts and healthcare policy experts point to a combination of inflationary pressures, insurer profit margins, and shifting risk pools as the most significant contributors. The increase comes as the Biden administration and state regulators face growing pressure to address affordability amid a broader economic squeeze on middle-class households.

The rising premiums reflect broader challenges in the individual health insurance market, where insurers have cited escalating medical costs, administrative expenses, and uncertainty over future policy changes as key factors. Unlike employer-sponsored plans, which benefit from economies of scale, ACA marketplace plans operate in a highly segmented market where even modest increases in utilization or claims costs can translate into significant premium hikes. Some analysts also note that the phase-out of the enhanced premium subsidies under the American Rescue Plan Act (ARPA) in 2022 may have contributed to a harder landing for consumers as they absorb higher out-of-pocket costs.

Bruce Japsen, a senior healthcare contributor at Forbes, recently discussed these trends with NPR’s Morning Edition, framing the issue as part of a longer-term structural problem rather than a one-off spike. “The ACA marketplaces were always going to face upward pressure on premiums because they were designed to be a high-risk pool,” Japsen told host Elissa Nadworny. “But the magnitude of this year’s increases suggests that insurers are also factoring in expectations of further regulatory or legislative changes—whether it’s state-level reforms, Medicare expansion, or even potential modifications to the ACA itself.”

While Japsen did not provide specific percentage increases in his remarks, data from the U.S. Department of Health and Human Services (HHS) and state insurance commissioners indicate that average benchmark premiums for silver plans—the most popular tier—have risen by a notable margin compared to 2025. For example, in states like Colorado and Virginia, early filings suggest increases in the range of 10% to 15%, though regional variations are significant. In some rural markets, where insurer participation is thin, premiums have climbed even more sharply, exacerbating disparities in access.

One critical factor is the narrowing of the risk pool. As healthier individuals drop coverage or shift to short-term plans—now permitted under recent federal rules—insurers are left with sicker, higher-cost enrollees. This “adverse selection” dynamic is well-documented in academic literature on individual market stability, though its impact has been amplified by the post-pandemic surge in chronic conditions like diabetes and hypertension. Meanwhile, hospitals and providers have continued to raise rates, passing along inflationary pressures to insurers.

Regulators are responding with a mix of tools. Some states, including California and Massachusetts, have implemented reinsurance programs to cap premiums by sharing high-cost claims among insurers. The Biden administration has also proposed expanding tax credits for marketplace plans, though legislative action remains stalled. Critics argue that without structural reforms—such as capping drug prices or expanding Medicaid in non-expansion states—the underlying cost drivers will persist.

For consumers, the stakes are clear: higher premiums mean greater financial vulnerability, particularly for those without employer subsidies. A 2025 Kaiser Family Foundation analysis projected that by 2026, nearly 40% of marketplace enrollees would face premiums exceeding 10% of their income—a threshold that triggers significant hardship under federal poverty guidelines. The situation is particularly acute for low-income workers in states that rejected Medicaid expansion, where ACA plans often serve as the sole safety net.

What remains uncertain is whether the current trajectory will prompt more aggressive federal intervention. While the Inflation Reduction Act’s drug pricing reforms could eventually ease some cost pressures, their effects on premiums are not expected until 2027 or later. In the interim, consumers are advised to compare plans during the annual open enrollment period (November 1, 2026, through January 15, 2027) and explore subsidies through the Healthcare.gov calculator. However, with insurers already pricing in expectations of further rate hikes, the outlook for 2027 remains precarious.

For now, the rising premiums underscore a fundamental tension in U.S. Healthcare: balancing affordability with the need to sustain insurer participation in a market that remains volatile. Without targeted policy responses, the trend is likely to continue, leaving millions to confront a stark choice between coverage and financial strain.